Moreover, high expression of heparanase is frequently observed in an increasing number of primary human tumors, such as prostate cancer, bladder cancer and gastric cancer, and the heparanase-facilitated invasion and metastasis induce poor outcomes in cancer patients [5]–[8]. Here, HPSE is linked to urinary bladder carcinoma.